当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1411
Allergan, Inc.
2008/1/22 0:00:00
NEBIVOLOL
DRUG FOR FURTHER PROCESSING
10
0456-1411_
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1421
Allergan, Inc.
2008/1/22 0:00:00
NEBIVOLOL
DRUG FOR FURTHER PROCESSING
20
0456-1421_
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1511
Allergan, Inc.
2009/4/17 0:00:00
MILNACIPRA
DRUG FOR FURTHER PROCESSING
100
0456-1511_
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1513
Allergan, Inc.
2009/4/17 0:00:00
MILNACIPRA
DRUG FOR FURTHER PROCESSING
12.5
0456-1513_
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1526
Allergan, Inc.
2009/4/17 0:00:00
MILNACIPRA
DRUG FOR FURTHER PROCESSING
25
0456-1526_
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1551
Allergan, Inc.
2009/4/17 0:00:00
MILNACIPRA
DRUG FOR FURTHER PROCESSING
50
0456-1551_
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
0456-2006
Allergan, Inc.
2002/8/14 0:00:00
ESCITALOPR
DRUG FOR FURTHER PROCESSING
5
0456-2006_
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
0456-2011
Allergan, Inc.
2002/8/14 0:00:00
ESCITALOPR
DRUG FOR FURTHER PROCESSING
10
0456-2011_
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
0456-2021
Allergan, Inc.
2002/8/14 0:00:00
ESCITALOPR
DRUG FOR FURTHER PROCESSING
20
0456-2021_
levomilnacipran hydrochloride
BULK INGREDIENT
0456-2213
Allergan, Inc.
2008/1/22 0:00:00
LEVOMILNAC
DRUG FOR FURTHER PROCESSING
120
0456-2213_
levomilnacipran hydrochloride
BULK INGREDIENT
0456-2221
Allergan, Inc.
2008/1/22 0:00:00
LEVOMILNAC
DRUG FOR FURTHER PROCESSING
20
0456-2221_
levomilnacipran hydrochloride
BULK INGREDIENT
0456-2241
Allergan, Inc.
2008/1/22 0:00:00
LEVOMILNAC
DRUG FOR FURTHER PROCESSING
40
0456-2241_
levomilnacipran hydrochloride
BULK INGREDIENT
0456-2281
Allergan, Inc.
2008/1/22 0:00:00
LEVOMILNAC
DRUG FOR FURTHER PROCESSING
80
0456-2281_
Asenapine Maleate
DRUG FOR FURTHER PROCESSING
0456-2404
Allergan, Inc.
2014/12/30 0:00:00
ASENAPINE
DRUG FOR FURTHER PROCESSING
2.5
0456-2404_
Asenapine Maleate
DRUG FOR FURTHER PROCESSING
0456-2407
Allergan, Inc.
2013/9/30 0:00:00
ASENAPINE
DRUG FOR FURTHER PROCESSING
5
0456-2407_
Asenapine Maleate
DRUG FOR FURTHER PROCESSING
0456-2412
Allergan, Inc.
2013/9/30 0:00:00
ASENAPINE
DRUG FOR FURTHER PROCESSING
10
0456-2412_
Memantine Hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3206
Allergan, Inc.
2003/10/16 0:00:00
MEMANTINE
DRUG FOR FURTHER PROCESSING
5
0456-3206_
Memantine Hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3211
Allergan, Inc.
2003/10/16 0:00:00
MEMANTINE
DRUG FOR FURTHER PROCESSING
10
0456-3211_
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3408
Allergan, Inc.
2011/10/31 0:00:00
MEMANTINE
DRUG FOR FURTHER PROCESSING
7
0456-3408_
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3415
Allergan, Inc.
2011/10/31 0:00:00
MEMANTINE
DRUG FOR FURTHER PROCESSING
14
0456-3415_
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3